Back to Agenda
Using Data Analytics for Good Pharmacovigilance Practices
Session Chair(s)
Kiernan Trevett, MSc
Quality Policy Lead
Genentech, A Member of the Roche Group, United States
This session will consist of perspectives and case studies of how data-driven solutions are being leveraged to support the development of quality assurance strategies for pharmacovigilance activities and to generate quality evidence in relation to Good Pharmacovigilance Practice (GVP) compliance.
Learning Objective : Investigate the use of data-driven solutions to develop quality assurance strategies for Good Pharmacovigilance Practice (GVP) activities and to generate quality evidence in relation to GVP compliance.
Speaker(s)
Industry Update
Michelle Ruiz
Genentech, A Member of the Roche Group, United States
Principal Quality Data Analyst
Industry Update
John Okudjeto, MSc
Janssen Research & Development LLC, United States
Manager, Pharmacovigilance QA
Inspector's Perspective
Sophie Radicke, MSc
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Head of GPvP and Senior Pharmacovigilance Inspector
Have an account?